Tilray's Record Revenue Falls Flat
Source: yahoo ·
Tilray Brands recently posted record fiscal 2026 revenue, but its stock has failed to capitalize on the milestone.
Key takeaways
- Tilray Brands posted record fiscal 2026 revenue of $915 million, an 11% increase.
- Adjusted EBITDA rose 11% to $61.1 million, but fell short of sell-side forecasts.
- Tilray reported net losses of $49.6 million, or negative 43 cents per share, on a GAAP basis.
- Management expects adjusted EBITDA of $68 million to $75 million for fiscal 2027, but may not translate to positive GAAP earnings.
- Tilray's debt has been cut to effectively zero, but through dilutive debt-for-equity swaps.
Why it matters
The lack of a strong stock rally despite Tilray's record revenue and promising guidance highlights the challenges the company faces in achieving profitability and maintaining investor interest. The situation has implications for the cannabis sector, as investors may be hesitant to invest in other companies with similar challenges. The market's reaction to Tilray's earnings and guidance will also influence the competitive landscape, as other companies may struggle to meet investor expectations for growth and profitability.
What to watch
- Tilray's next quarterly earnings release, which may provide a significant improvement in results.
- The U.S. federal government's marijuana rescheduling efforts, which could increase Tilray's exposure to the cannabis market.
- Tilray's ability to maintain its current revenue growth and adjust its business strategy to improve profitability.